- Report
- February 2024
- 175 Pages
Global
From €4818EUR$5,000USD£4,144GBP
- Report
- May 2024
- 93 Pages
Global
From €5396EUR$5,600USD£4,642GBP
- Drug Pipelines
- April 2024
- 230 Pages
Global
From €2891EUR$3,000USD£2,487GBP
- Report
- November 2023
- 178 Pages
Global
From €4722EUR$4,900USD£4,061GBP
- Report
- July 2023
- 159 Pages
Global
From €2409EUR$2,500USD£2,072GBP
- Report
- October 2023
- 138 Pages
North America
From €4240EUR$4,400USD£3,647GBP
- Report
- March 2024
- 188 Pages
Global
From €3251EUR$3,374USD£2,797GBP
€3612EUR$3,749USD£3,107GBP
- Report
- November 2023
- 182 Pages
Global
From €4722EUR$4,900USD£4,061GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Report
- March 2024
- 190 Pages
Global
From €3251EUR$3,374USD£2,797GBP
€3612EUR$3,749USD£3,107GBP
- Report
- December 2023
- 110 Pages
Global
From €5733EUR$5,950USD£4,932GBP
- Report
- November 2023
- 190 Pages
Global
From €1918EUR$1,990USD£1,649GBP
- Report
- June 2023
- 145 Pages
Global
From €2408EUR$2,499USD£2,071GBP
- Report
- February 2020
- 600 Pages
Global
From €3854EUR$4,000USD£3,315GBP
- Report
- August 2022
- 148 Pages
Global
From €5300EUR$5,500USD£4,559GBP
- Report
- November 2022
- 120 Pages
Global
From €5733EUR$5,950USD£4,932GBP
- Report
- February 2022
- 172 Pages
Global
From €2881EUR$2,990USD£2,478GBP
- Report
- April 2023
- 144 Pages
Global
From €2843EUR$2,950USD£2,445GBP
The Head and Neck Cancer Drug market is a subset of the larger Oncology Drugs market. It includes drugs used to treat cancers of the head and neck, such as squamous cell carcinoma, salivary gland cancer, and nasopharyngeal cancer. These drugs are typically used in combination with radiation therapy and/or surgery to treat the cancer. Common drugs used in this market include chemotherapy, targeted therapy, immunotherapy, and monoclonal antibodies.
The Head and Neck Cancer Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in this market include Bristol-Myers Squibb, Merck & Co., Pfizer, AstraZeneca, and Roche. Other companies include Novartis, Eli Lilly, and GlaxoSmithKline. Show Less Read more